» Articles » PMID: 11750098

Circulating PIG-A Mutant T Lymphocytes in Healthy Adults and Patients with Bone Marrow Failure Syndromes

Overview
Journal Exp Hematol
Specialty Hematology
Date 2001 Dec 26
PMID 11750098
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematological disorder with acquired PIG-A gene mutations and absent surface expression of proteins utilizing glycosylphosphatidylinositol (GPI) anchors. PNH often follows aplastic anemia, suggesting PIG-A mutant cells have relative dominance over normal hematopoietic cells. Somatic PIG-A mutations could arise after aplasia, or healthy persons could have rare PIG-A mutant cells that expand under selection pressure.

Methods: We developed an in vitro negative selection method to isolate GPI-deficient T lymphocytes using aerolysin, an Aeromonas toxin that binds GPI anchors and induces cell lysis. Peripheral blood mononuclear cells (PBMC) from normal adults and patients with PNH or other bone marrow failure syndromes were analyzed.

Results: From healthy adults, 166 T lymphocyte clones with deficient GPI-linked surface protein expression (CD55, CD59) were isolated. The mean mutant frequency (M(f)) of aerolysin-resistant clones was 17.8 +/- 13.8 per 10(6) PBMC, range 5.0-59.6 per 10(6) cells. Clones had a Class A complementation defect and distinct PIG-A mutations. Patients with PNH had elevated aerolysin-resistant M(f) values averaging 19 x 10(-2), a 10,000-fold difference. Two patients with Fanconi anemia and two others with mild aplastic anemia had M(f) values less than 15 x 10(-6), but two with recovering aplastic anemia had M(f) values of 20 x 10(-4), representing an intermediate value between normal persons and PNH patients.

Conclusion: Identification of PIG-A mutant T lymphocytes in healthy adults suggests PNH could develop following intense negative selection of hematopoiesis, with clonal outgrowth of naturally occurring PIG-A mutant stem cells.

Citing Articles

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.

Kaitz N, Zuleger C, Yu P, Newton M, Albertini R, Albertini M Mutat Res Rev Mutat Res. 2022; 789:108414.

PMID: 35690417 PMC: 9188651. DOI: 10.1016/j.mrrev.2022.108414.


The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center.

Pires da Silva B, Fonseca N, Catto L, Pereira G, Calado R Ann Hematol. 2022; 101(5):999-1007.

PMID: 35182190 PMC: 8993788. DOI: 10.1007/s00277-022-04797-9.


CRISPR/Cas9 gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.

Shin T, Baek E, F Corat M, Chen S, Metais J, Aljanahi A Blood. 2019; 133(23):2542-2545.

PMID: 31003997 PMC: 6557622. DOI: 10.1182/blood.2019000800.


Mutation in PIGA results in a CD52-negative escape variant in a Sézary syndrome patient during alemtuzumab treatment.

Halkes C, Zoutman W, van der Fits L, Jedema I, Vermeer M J Invest Dermatol. 2014; 135(4):1199-1202.

PMID: 25431852 DOI: 10.1038/jid.2014.501.


Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with acute lymphoblastic leukemia.

Araten D, Sanders K, Anscher D, Zamechek L, Hunger S, Ibrahim S Am J Pathol. 2012; 181(5):1862-9.

PMID: 22940070 PMC: 3483812. DOI: 10.1016/j.ajpath.2012.07.025.